These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21821544)

  • 21. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinomas of an unknown primary origin--diagnosis and treatment.
    Massard C; Loriot Y; Fizazi K
    Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the diagnostic methods in head and neck cancer of unknown primary site.
    Aro K; Bäck L; Mäkitie A; Tapiovaara L
    Acta Otolaryngol; 2018 Oct; 138(10):930-936. PubMed ID: 30016889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
    Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
    Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
    Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive diagnostic work-up for patients with carcinoma of unknown primary.
    Meijer L; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP; Loef C
    Clin Exp Metastasis; 2021 Apr; 38(2):231-238. PubMed ID: 33515369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.
    Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G
    Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care.
    Creak A
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathological diagnostics of CUP (Cancer of Unknown Primary)].
    Tímár J
    Magy Onkol; 2019 Jun; 63(2):67-74. PubMed ID: 31225529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer of unknown primary: time trends in incidence, United States.
    Mnatsakanyan E; Tung WC; Caine B; Smith-Gagen J
    Cancer Causes Control; 2014 Jun; 25(6):747-57. PubMed ID: 24710663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiological diagnostics in CUP syndrome].
    Kazmierczak PM; Nikolaou K; Rominger A; Graser A; Reiser MF; Cyran CC
    Radiologe; 2014 Feb; 54(2):117-23. PubMed ID: 24500247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
    Pauli C; Bochtler T; Mileshkin L; Baciarello G; Losa F; Ross JS; Pentheroudakis G; Zarkavelis G; Yalcin S; Özgüroğlu M; Beringer A; Scarato J; Mueller-Ohldach M; Thomas M; Moch H; Krämer A
    Oncologist; 2021 May; 26(5):e769-e779. PubMed ID: 33687747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.